HB Wealth Management LLC Sells 8,389 Shares of Aspen Aerogels, Inc. (NYSE:ASPN)

HB Wealth Management LLC decreased its stake in shares of Aspen Aerogels, Inc. (NYSE:ASPN) by 39.3% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 12,974 shares of the construction company’s stock after selling 8,389 shares during the period. HB Wealth Management LLC’s holdings in Aspen Aerogels were worth $154,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently modified their holdings of the stock. Point72 Hong Kong Ltd bought a new position in shares of Aspen Aerogels in the 2nd quarter worth about $84,000. Quent Capital LLC bought a new stake in Aspen Aerogels during the third quarter worth about $118,000. Point72 DIFC Ltd purchased a new stake in Aspen Aerogels in the second quarter worth about $121,000. Public Employees Retirement Association of Colorado bought a new position in shares of Aspen Aerogels during the second quarter valued at approximately $145,000. Finally, nVerses Capital LLC lifted its holdings in shares of Aspen Aerogels by 45.0% during the third quarter. nVerses Capital LLC now owns 5,800 shares of the construction company’s stock valued at $161,000 after purchasing an additional 1,800 shares during the last quarter. Hedge funds and other institutional investors own 97.64% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities analysts have recently weighed in on the company. HC Wainwright restated a “buy” rating and set a $30.00 price target on shares of Aspen Aerogels in a report on Wednesday, October 16th. Piper Sandler decreased their target price on shares of Aspen Aerogels from $36.00 to $33.00 and set an “overweight” rating for the company in a report on Tuesday, October 22nd. Barclays cut their price target on shares of Aspen Aerogels from $27.00 to $25.00 and set an “overweight” rating on the stock in a report on Tuesday, November 12th. Roth Mkm decreased their price target on Aspen Aerogels from $36.00 to $31.00 and set a “buy” rating for the company in a research note on Friday, November 8th. Finally, Canaccord Genuity Group dropped their price objective on Aspen Aerogels from $28.00 to $20.00 and set a “buy” rating on the stock in a research report on Thursday, January 16th. One equities research analyst has rated the stock with a sell rating, eight have given a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $29.11.

Aspen Aerogels Price Performance

Shares of Aspen Aerogels stock opened at $11.50 on Friday. The company has a quick ratio of 2.48, a current ratio of 2.93 and a debt-to-equity ratio of 0.27. Aspen Aerogels, Inc. has a 52 week low of $10.75 and a 52 week high of $33.15. The stock’s 50-day simple moving average is $13.09 and its 200-day simple moving average is $19.81. The company has a market capitalization of $943.16 million, a price-to-earnings ratio of 1,150.65 and a beta of 2.14.

Aspen Aerogels Company Profile

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.